Economic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary disease.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 17136989)

Published in COPD on January 01, 2004

Authors

José Luis Izquierdo-Alonso1, J de Miguel-Díez

Author Affiliations

1: Section of Pneumology, Hospital General Universitario de Guadalajara, Guadalajara, Spain. jlizquierdo@sescam.org